Johns Hopkins ABX Guide
Pretomanid
INDICATIONS
FDA
FDA
- Treatment of adults with pulmonary extensively drug-resistant (XDR) TB and treatment-intolerant or nonresponsive multidrug-resistant (MDR) TB in a combination regimen with bedaquiline and linezolid.
- Limitations of Use: Pretomanid is not indicated for patients with drug-sensitive TB, latent TB, extra-pulmonary infection due to M. tuberculosis, MDR-TB that is not treatment-intolerant or nonresponsive to standard therapy
- Safety and effectiveness have not been established in combination with drugs other than bedaquiline and linezolid.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: February 10, 2020
Citation
Avdic, Edina. "Pretomanid." Johns Hopkins ABX Guide, The Johns Hopkins University, 2020. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540726/all/Pretomanid.
Avdic E. Pretomanid. Johns Hopkins ABX Guide. The Johns Hopkins University; 2020. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540726/all/Pretomanid. Accessed December 12, 2024.
Avdic, E. (2020). Pretomanid. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540726/all/Pretomanid
Avdic E. Pretomanid [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2020. [cited 2024 December 12]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540726/all/Pretomanid.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pretomanid
ID - 540726
A1 - Avdic,Edina,Pharm.D.
Y1 - 2020/02/10/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540726/all/Pretomanid
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
